Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 14, 2026, titled “Alembic Pharmaceuticals Limited receives USFDA Tentative Approval for Darolutamide Tablets, 300 mg.”. |SUBJECT: Press Release
- 500x Leverage
- Pay-In/Out in 10 Min
- Start MCX from ₹1000
- Lowest Brokerage
- Up to 500x Leverage
- Lowest Brokerage in the market
- Account Opening in Just 10 Minutes
- Instant Deposit & Withdrawal within 10 minutes
- Start Trading with Just ₹500